Z. Rankovic
Computational Theory and Mathematics · 2004–2015
A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Subfields
- Computational Theory and Mathematics — 18 citations into it; #5,303 of 12,182 by trust here, #4,059 by citations
- Oncology — 17 citations into it; #421 of 1,698 by trust here, #1,582 by citations
- Pharmacology — 11 citations into it; #226 of 1,112 by trust here, #945 by citations
- Pediatrics, Perinatology and Child Health — 5 citations into it
Whom Z. Rankovic trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Z. Rankovic overall
Papers from Z. Rankovic's perspective
Ordered by how strongly the researchers Z. Rankovic trusts endorse each paper. Same corpus, a different order for every researcher.
- Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice (Journal of Cell Biology)
- Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
- The superfamily of organic anion transporting polypeptides. (Biochimica et Biophysica Acta)
- A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases.
- Blood-brain barrier active efflux transporters: ATP-binding cassette gene family (NeuroRx)
- Lead- and drug-like compounds: the rule-of-five revolution. (Drug Discovery Today : Technologies)
- Physiochemical drug properties associated with in vivo toxicological outcomes. (Bioorganic & Medicinal Chemistry Letters)
- Molecular properties that influence the oral bioavailability of drug candidates. (Journal of Medicinal Chemistry)
- Global mapping of pharmacological space
- Sniffing neuropeptides: a transnasal approach to the human brain (Nature Neuroscience)
Their papers
- From magic bullets to designed multiple ligands. (2004) — 629 citations
- Designed multiple ligands. An emerging drug discovery paradigm. (2005) — 1,074 citations
- CNS drug design: balancing physicochemical properties for optimal brain exposure. (2015) — 471 citations